Related Experiment Video
Updated: Feb 23, 2026

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
Published on: March 31, 2022
Intravenous polymyxins: Revival with puzzle
Yun Yu1, Aihua Fei1, Zengbin Wu1
1Department of Emergency, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine.
Polymyxins are effective last-resort treatments for multidrug-resistant infections, showing improved efficacy and reduced toxicity in recent trials. Optimal combination therapies and dosing strategies require further investigation through larger prospective studies.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Rising incidence of multidrug-resistant (MDR) bacterial strains, particularly carbapenem-resistant Enterobacteriaceae (CRE).
- Polymyxins (colistin and polymyxin B) are experiencing a resurgence as last-resort agents for treating MDR infections.
Purpose of the Study:
- To evaluate the efficacy and safety of polymyxin-based regimens for multidrug-resistant infections.
- To explore the role of combination therapy versus monotherapy and identify optimal combination agents.
- To review current evidence on polymyxin dosing strategies and potential toxicities.
Main Methods:
- Systematic review and analysis of data from 47 clinical trials and case series.
- Comparison of outcomes for polymyxin monotherapy and combination therapy.
- Assessment of clinical response, mortality, and microbiological eradication rates.
Main Results:
- Polymyxin-based regimens demonstrated effectiveness and reduced toxicity compared to historical data.
- Intravenous polymyxin monotherapy showed variable outcomes: mortality (0–74.3%), clinical response (7–82.1%), and microbiological eradication (27.3–73.9%).
- Combination therapy appears more effective than monotherapy, though further evidence is needed. Optimal combinations and dosing remain unconfirmed.
Conclusions:
- Polymyxins are valuable in treating challenging MDR infections, but controversies persist regarding optimal combination regimens and dosing.
- Loading dose regimens may enhance efficacy, but careful monitoring for adverse effects, especially nephrotoxicity, is crucial.
- Further large-scale prospective trials are essential to clarify optimal polymyxin use, particularly concerning dosing and combination strategies for colistin and polymyxin B.
More Related Videos
Related Concept Videos
Pharmaceutical Poisoning: Treatment Strategies
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections

